CUSIP: 30063P105
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
193,646,400
-
Total 13F shares
-
114,811,544
-
Share change
-
+5,576,625
-
Total reported value
-
$13,532,261,559
-
Put/Call ratio
-
210%
-
Price per share
-
$118.04
-
Number of holders
-
466
-
Value change
-
+$672,041,608
-
Number of buys
-
241
-
Number of sells
-
194
Security key
30063P105
Report period
Q2 2019
Institutions
466
Top holders
10
Reporting periods
Holder history for CUSIP 30063P105
Recent filing periods:
Top shareholders of EXAS - EXACT SCIENCES CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of EXACT SCIENCES CORP - Common Stock (EXAS) as of Q2 2019
As of 30 Jun 2019,
EXACT SCIENCES CORP - Common Stock (EXAS) was held by
466 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,811,544 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, AMERIPRISE FINANCIAL INC, JENNISON ASSOCIATES LLC, Invesco Ltd., and STATE STREET CORP.
This page lists
466
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2019 vs Q1 2019 Across Filers
| Investor |
Q1 2019 Shares |
Q2 2019 Shares |
Share Diff |
Share Chg % |
Q1 2019 Value $ |
Q2 2019 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.